A prospective multi-center investigational study of IMMray
Brief description of study
Brief Summary:
PanFAM-1 is a clinical study for early detection of pancreatic cancer in high-risk groups. The goals of the study are to assess the performance and diagnostic accuracy of the IMMray™ PanCan-d test compared to standard-of-care imaging.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
pancreas
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
01 Aug 2022.
Study ID: 831292
